Close
  Indian J Med Microbiol
 

Figure 4: HSP90α expression in nipple discharge was higher than that in blood. (a-c) There was no significant difference in the expression of HSP90α, CEA, and CA153 in the blood of patients benign disease and breast cancer (116 samples were available for CEA detection, 115 samples for CA153 detection, and 47 samples for HSP90α detection). (d) HSP90α expression in nipple discharge and blood was concurrently detected in 47 patients. The results showed that the expression of HSP90α in nipple discharge was significantly higher than that in blood (P = 0.0003). (e) Among the 47 patients, 29 (61.7%) had higher HSP90α expression in nipple discharge than in blood. CEA: Carcinoembryonic antigen, CA153: Cancer antigen 153, HSP90α: Heat shock protein 90α.

Figure 4: HSP90α expression in nipple discharge was higher than that in blood. (a-c) There was no significant difference in the expression of HSP90α, CEA, and CA153 in the blood of patients benign disease and breast cancer (116 samples were available for CEA detection, 115 samples for CA153 detection, and 47 samples for HSP90α detection). (d) HSP90α expression in nipple discharge and blood was concurrently detected in 47 patients. The results showed that the expression of HSP90α in nipple discharge was significantly higher than that in blood (<i>P</i> = 0.0003). (e) Among the 47 patients, 29 (61.7%) had higher HSP90α expression in nipple discharge than in blood. CEA: Carcinoembryonic antigen, CA153: Cancer antigen 153, HSP90α: Heat shock protein 90α.